Omnicell’s Enhanced Profitability and Strategic Initiatives Drive Buy Rating with Increased Price Target

Analyst Stan Berenshteyn from Wells Fargo reiterated a Buy rating on Omnicell (OMCL – Research Report) and increased the price target to $37.00 from $35.00.

Stan Berenshteyn has given his Buy rating due to a combination of factors, including Omnicell’s improved guidance outlook and the potential positive impact of reduced tariff rates. The company’s adjusted EBITDA guidance for 2025 has been raised significantly, indicating a stronger financial performance than previously anticipated. Although revenue projections remain unchanged, the adjustments to EBITDA estimates suggest a meaningful improvement, which supports a more optimistic view of the company’s future profitability.
Furthermore, Omnicell’s authorization of a $75 million share repurchase program indicates confidence in its financial health and potential for shareholder value enhancement. The price target has been increased to $37, based on a balanced approach using both multiple-based and DCF-based valuations. This revised target reflects the company’s improved earnings outlook and strategic initiatives, making it an attractive investment opportunity.

OMCL’s price has also changed moderately for the past six months – from $45.690 to $28.840, which is a -36.88% drop .